Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06929572 · ClinicalTrials.gov registry record · NA
Autologous Human Umbilical Cord Tissue Patch for Postnatal Closure of Open Neural Tube Defects
A NA study of Spina Bifida, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06929572: Recruiting NA study of Spina Bifida, sponsored by The University of Texas Health Science Center, Houston.
NCT06929572 is a NA study of Spina Bifida that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 15 participants, below the 52-participant average among 16 other Spina Bifida trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06929572, a NA study of Spina Bifida, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the impact of an autologous umbilical cord patch for dural closure on the repair of open neural tube defect. The outcomes will evaluate successful defect closure, creation of a more capacious spinal canal, and reduction in inflammatory tissue response versus historical controls.
Conditions Studied
Interventions
- PROCEDURE Autologous umbilical cord patch
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-08-05 |
| Est. Completion | 2033-01 |
| Phase | NA |
What NCT06929572 shows while recruiting
NCT06929572 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 52-participant average among 16 other Spina Bifida trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Spina Bifida appearing as the primary indexed condition, and to 1 intervention - of which Autologous umbilical cord patch is the first listed.
NCT06929572 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06929572 about?
NCT06929572 is a clinical study titled "Autologous Human Umbilical Cord Tissue Patch for Postnatal Closure of Open Neural Tube Defects". The purpose of this study is to determine the impact of an autologous umbilical cord patch for dural closure on the repair of open neural tube defect. The outcomes will evaluate successful defect closure, creation of a more capacious spinal canal, and reduction in inflammatory tissue response versus...
What is the current status of trial NCT06929572?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-08-05. Estimated completion is 2033-01.
What conditions does trial NCT06929572 study?
This clinical trial studies the following conditions: Spina Bifida.
What interventions are being tested in trial NCT06929572?
The interventions under investigation include: Autologous umbilical cord patch (PROCEDURE).
Who is sponsoring clinical trial NCT06929572?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06929572 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spina Bifida
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06929572's enrollment target sits among peer trials
15 12th of 16 higher than 5 of 16 other Spina Bifida trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spina Bifida trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder
RECRUITING · NA
-
Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
RECRUITING · NA
-
Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida
RECRUITING · NA
-
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
RECRUITING · NA
-
In-Utero Endoscopic Correction of Spina Bifida
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI